Back to search

University of Southampton

How point mutations confer resistance in BCR-ABL: a computational study

Abstract

dc:description.abstract

Imatinib is a first generation BCR-Abl tyrosine kinase inhibitor widely used in the treatment of CML. A significant cause of relapse in patients receiving imatinib therapy can be attributed to the development of point mutations in the BCR-Abl tyrosine kinase and resulting imatinib-resistance. Nilotinib is one of several second generation BCR-Abl tyrosine kinase inhibitors developed to treat imatinib-resistant CML. Nilotinib inhibits the majority of imatinib-resistant mutations, however mutations that are resistant to both imatinib and nilotinib persist in patients. These highly resistant mutations include compound mutants, where multiple mutations occur in the same BCR-Abl molecule. Further understanding regarding how mutations confer resistance and the ability to predict the resistance profile of a given compound mutation would enable drug design initiatives, both in CML and other cancers, to be improved in the future.<br/><br/>In this thesis three major computational approaches; molecular dynamics, ligand docking and MM-GBSA have been applied to investigate the effects of single and compound point mutations in the BCR-Abl kinase domain. Wild-type structures of BCR-Abl were studied initially in order to validate methods and act as a benchmark for comparison against the mutant structures. A total of ten mutant structures of inactive BCR-Abl were studied; five in complex with imatinib and five with nilotinib. Using this approach we were able to rank the single mutant structures according to experimental data and test the protocol on two previously unstudied compound mutations

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Clapton, Genevieve
Advisor dc:contributor.advisor
  • Essex, Jonathan
ORCID person:identifier.orcid

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Clapton, Genevieve. How point mutations confer resistance in BCR-ABL: a computational study. doctoral thesis, University of Southampton, 2015.